Perforin dependence of natural killer cell‐mediated tumor control in vivo
暂无分享,去创建一个
[1] R. Zinkernagel,et al. Lymphocyte‐mediated Cytotoxicity in vitro and in vivo: Mechanisms and Significance , 1995, Immunological reviews.
[2] P. A. Peterson,et al. A viral inhibitor of peptide transporters for antigen presentation , 1995, Nature.
[3] J. Yewdell,et al. Herpes simplex virus turns off the TAP to evade host immunity , 1995, Nature.
[4] Eric O Long,et al. Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. , 1995, Immunity.
[5] M. Colonna,et al. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. , 1995, Science.
[6] K. Kärre. Express yourself or die: peptides, MHC molecules, and NK cells. , 1995, Science.
[7] C. Walsh,et al. The role of the Fas lytic pathway in a perforin-less CTL hybridoma. , 1994, Journal of immunology.
[8] J. Tschopp,et al. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways , 1994, Nature.
[9] S. Yonehara,et al. Cytotoxicity of fresh NK1.1+ T cell receptor alpha/beta+ thymocytes against a CD4+8+ thymocyte population associated with intact Fas antigen expression on the target , 1994, The Journal of experimental medicine.
[10] K. Okumura,et al. Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes. , 1994, Immunity.
[11] H Hengartner,et al. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. , 1994, Science.
[12] Hans Hengartner,et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice , 1994, Nature.
[13] P. Golstein,et al. Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity , 1993, The Journal of experimental medicine.
[14] T. Mak,et al. CD8 is needed for development of cytotoxic T but not helper T cells , 1991, Cell.
[15] G. Klein,et al. Afferent and efferent cellular interactions in natural resistance directed against MHC class I deficient tumor grafts. , 1988, Journal of immunology.
[16] H. Ljunggren,et al. Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy , 1986, Nature.
[17] S. Segal,et al. Abrogation of metastatic properties of tumour cells by de novo expression of H–2K antigens following H–2 gene transfection , 1985, Nature.
[18] H. Ljunggren,et al. Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism , 1985, The Journal of experimental medicine.
[19] R. Kiessling,et al. „Natural”︁ killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype , 1975, European journal of immunology.
[20] P. Bruggen,et al. Tumor antigens recognized by T lymphocytes. , 1994, Annual review of immunology.
[21] C. Melief,et al. Tumor eradication by adoptive transfer of cytotoxic T lymphocytes. , 1992, Advances in cancer research.
[22] P. Greenberg. Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells. , 1991, Advances in immunology.
[23] P. Henkart. Mechanism of lymphocyte-mediated cytotoxicity. , 1985, Annual review of immunology.
[24] M. Chase. Immunology and experimental dermatology. , 1985, Annual review of immunology.
[25] P. Doherty,et al. Immunological surveillance of tumors in the context of major histocompatibility complex restriction of T cell function. , 1984, Advances in cancer research.
[26] A. Eb,et al. Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells , 1983, Nature.
[27] C. Melief,et al. Tumorigenicity of cells transformed by adenovirus type 12 by evasion of T-cell immunity , 1983, Nature.